The RAD51C gene encodes a protein crucial for DNA repair. Variants in this gene that stop the protein from working are known to increase the risk of breast and ovarian cancers and rarely, ...

The gene RAD51C is a “cancer protection” gene that encodes a protein crucial for DNA repair. Variants in this gene that stop the protein from working are known to increase the risk of breast ...

The RAD51C gene encodes a protein crucial for DNA repair. Variants in this gene that stop the protein from working are known to increase the risk of breast and ovarian cancers and rarely, ...

The current agreement grants Myriad an exclusive, worldwide license, with co-exclusivity in Germany, to provide commercial testing for RAD51C.

The RAD51C gene encodes a protein crucial for DNA repair. Variants in this gene that stop the protein from working are known to increase the risk of breast and ovarian cancers and rarely, ...

Heterozygous carriers of germ-line mutations in the BRCA2/FANCD1, PALB2/FANCN and RAD51C/FANCO DNA repair genes have an increased lifetime risk of developing breast, ovarian and other cancers; bi ...

More information: Ksenija Nesic et al, Acquired RAD51C promoter methylation loss causes PARP inhibitor resistance in high grade serous ovarian carcinoma, Cancer Research (2021). DOI: 10.1158/0008 ...

In addition, mutations in BRIP1 and RAD51C were linked to more moderate risks of triple-negative disease. This study is the first to establish which genes are associated with high lifetime risks ...

Myriad Genetics ( MYGN ), in order to further expand its product portfolio, obtained rights to the RAD51C gene. Studies have shown that mutations in.

Myriad Genetics, Inc. announced it has obtained an exclusive license to intellectual property covering the analysis of the RAD51C gene for risk of hereditary breast and ovarian cancer. In several ...